Home / Share Price Target / Suvenphar
Suven Pharmaceuticals Share Price Target 2024, 2025, 2026 to 2039 With Charts
Suven Pharmaceuticals Limited | |||
 | Symbol: SUVENPHAR | ||
| Price: ₹1,279.55 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Suven Pharmaceuticals Brief Company Overview
- 1.1: Suven Pharmaceuticals: A Bio-Pharmaceutical Powerhouse
- 1.2: Suven Pharmaceuticals Financial Performance
- 1.2.1: Is Suven Pharmaceuticals A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Suven Pharmaceuticals Share Price Target For 2024
- 2.1.1: Suven Pharmaceuticals Share Price Target Table For 2024
- 2.1.2: Summary: Suven Pharmaceuticals Share Price Prediction For 2024
- 2.2: Suven Pharmaceuticals Share Price Target For 2025
- 2.2.1: Suven Pharmaceuticals Share Price Target Table For 2025
- 2.2.2: Summary: Suven Pharmaceuticals Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Suven Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Suven Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Suven Pharmaceuticals Past Performance
Suven Pharmaceuticals Brief Company Overview
Suven Pharmaceuticals: A Bio-Pharmaceutical Powerhouse
Suven Pharmaceuticals Limited, established in 2018, is a biopharmaceutical company with a global presence. Headquartered in Hyderabad, India, Suven operates under Berhyanda Limited.
Key Products and Services:
- New chemical entity-based intermediates
- Active pharmaceutical ingredients
- Specialty chemicals
- Formulated drugs
- Contract research and manufacturing services
Suven's comprehensive product range caters to pharmaceutical, biotechnology, and chemical industries.
Reputation and Commitment:
Suven has earned a reputation for its commitment to quality and innovation. The company's diverse product offerings and global presence are a testament to its unwavering commitment to cater to the evolving needs of the industry.
Suven Pharmaceuticals Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 16,397.8 Crore | Market valuation of Suven Pharmaceuticals's shares. |
| Revenue (TTM) | 1,167.77 Crore | Total revenue generated by Suven Pharmaceuticals over the past twelve months. |
| Net Income (TTM) | +370.87 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 23.83% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 31.75% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -37.9% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -56.6% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 1.74 | Company's total debt divided by total shareholder equity. |
| Total Debt | 34.5 Crore | Sum of Suven Pharmaceuticals's current & long-term financial obligations. |
| Total Cash | 753.5 Crore | Total amount of liquid funds available to Suven Pharmaceuticals. |
| Beta | 1.36 | Beta is greater than 1 indicating that the Suven Pharmaceuticals's price is more volatile than the market. |
Is Suven Pharmaceuticals A Good Buy For Long Term?
Suven Pharmaceuticals, with a market cap of ₹16,092 crore, has shown mixed financial performance. While revenue has declined in the past quarter (-37.9%), the company has maintained a stable net profit margin (31.75%). Despite a significant decline in earnings compared to last year (-56.6%), its long-term returns remain positive. Considering its moderate debt and strong cash balance, Suven Pharmaceuticals could be considered as an average buy for long-term investment with moderate risk tolerance.
To predict the Suven Pharmaceuticals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Suven Pharmaceuticals Share Price Target For 2024
The line chart displays the monthly closing prices of Suven Pharmaceuticals with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Suven Pharmaceuticals shares in 2024, see the table below.
Suven Pharmaceuticals Share Price Target Table For 2024
| Suven Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 1312.50 (+2.57%) | Price Action: 06 Nov 2024 Low |
| 2024 Target 2 | 1299.00 (+1.52%) | Price Action: 28 Oct 2024 High |
| 2024 Target 1 | 1285.90 (+0.49%) | Price Action: 11 Nov 2024 High |
| Current Price | 1279.55 | Suven Pharmaceuticals's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 1276.69 (-0.23%) | Price Action: 07 Nov 2024 Low |
| Stop Loss 2 | 1260.37 (-1.5%) | Fibonacci Retracement Extended 28.2% |
| Stop Loss 3 | 1244.59 (-2.74%) | Price Action: 24 Oct 2024 Low |
Summary: Suven Pharmaceuticals Share Price Prediction For 2024
In summary, Suven Pharmaceuticals has surged by ₹556.75, achieving a notable +77.03% increase from 1st January 2024 to 19 Nov 2024. Our analysis of Suven Pharmaceuticals for 2024 predicts an additional rise of 0.49% to 2.57% by the end of 2024 with three potential targets T1: 1285.90, T2: 1299.00, T3: 1312.50. Stop Loss at SL1: 1276.69, SL2: 1260.37, SL3: 1244.59.
Suven Pharmaceuticals has a 52-week high of ₹1353.94, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹577.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Suven Pharmaceuticals.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Suven Pharmaceuticals Share Price Target For 2025
The line chart displays the monthly closing prices of Suven Pharmaceuticals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Suven Pharmaceuticals shares in 2025, see the table below.
Suven Pharmaceuticals Share Price Target Table For 2025
| Suven Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 1839.84 (+43.78%) | Price Action: Chart |
| 2025 Target 2 | 1805.53 (+41.1%) | Price Action: Chart |
| 2025 Target 1 | 1787.65 (+39.7%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 1279.55 | Suven Pharmaceuticals's 1 share price as of Tue 19 Nov 2024 |
| Stop Loss 1 | 1151.05 (-10.05%) | Price Action: Sep 2024 Low |
| Stop Loss 2 | 1139.54 (-10.95%) | Price Action: Chart |
| Stop Loss 3 | 1119.03 (-12.55%) | Price Action: Chart |
Summary: Suven Pharmaceuticals Share Price Prediction For 2025
In summary, Suven Pharmaceuticals has surged by ₹556.75, achieving a notable +77.03% increase from 1st January 2024 to 19 Nov 2024. Our analysis of Suven Pharmaceuticals for 2025 predicts an additional rise of 39.7% to 43.78% by the end of 2025 with three potential targets T1: 1787.65, T2: 1805.53, T3: 1839.84. Stop Loss at SL1: 1151.05, SL2: 1139.54, SL3: 1119.03.
Suven Pharmaceuticals has a All-Time high of ₹1353.94, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹577.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Suven Pharmaceuticals, we have created a specific page for that check here: Suven Pharmaceuticals Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Suven Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Suven Pharmaceuticals share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 18.47% over the next 15 years.
For complete year by year Suven Pharmaceuticals long term share price target from 2024, 2025 to 2039 check the below table.
Suven Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Suven Pharmaceuticals Target | YoY Change % |
|---|---|---|
| 2024 | ₹1,279.55 | [Current Price] |
| 2024 | ₹1,419.23 | 10.91% |
| 2025 | ₹2,436.69 | 71.69% |
| 2026 | ₹3,409.46 | 39.92% |
| 2027 | ₹4,366.66 | 28.07% |
| 2028 | ₹5,006.45 | 14.65% |
| 2029 | ₹6,093.75 | 21.71% |
| 2030 | ₹7,275.17 | 19.38% |
| 2031 | ₹8,255.14 | 13.47% |
| 2032 | ₹9,199.12 | 11.43% |
| 2033 | ₹9,542.87 | 3.73% |
| 2034 | ₹10,768.27 | 12.84% |
| 2035 | ₹12,113.65 | 12.49% |
| 2036 | ₹13,100.82 | 8.14% |
| 2037 | ₹14,031.58 | 7.1% |
| 2038 | ₹14,079.31 | 0.34% |
| 2039 | ₹15,221.89 | 8.11% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Suven Pharmaceuticals Past Performance
- In 2020, Suven Pharmaceuticals opening price was ₹99.38
- As of Tue 19 Nov 2024 the price stands at ₹1,279.55.
- This represents a Compound Annual Growth Rate (CAGR) of 66.71%.
- In 4 years, an investment of 10,000 would have become ₹1.28 Lakh.
As we wrap up, we hope you like our study on Suven Pharmaceuticals share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Suven Pharmaceuticals Share Price History
- Suven Pharmaceuticals Price Target Tomorrow
- Suven Pharmaceuticals Dividend History
- Suven Pharmaceuticals Bonus History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
